Compare AFLAC Incorporated (AFL) vs Avient Corporation (AVNT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AFLAC Incorporated vs Avient Corporation — how do they compare? AFLAC Incorporated trades at $121.51 (market cap $61.84B), while Avient Corporation trades at $35.29 (market cap $3.49B). The key difference: AFLAC Incorporated is far larger — about 17.7× Avient Corporation's market cap, and Avient Corporation pays the higher dividend (2.89%). Which is the better fit depends on your goals.
| AFL | AVNT | |
|---|---|---|
Market Cap | $61.84B | $3.49B |
Sector | Financials | Technology |
52-Week High | $121.49 | $43.28 |
52-Week Low | $98.09 | $27.48 |
Enterprise Value | $70.50B | $4.99B |
Dividend Yield | 2.01% | 2.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aflac (AFL) trades at $121.49, up 0.5% with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a 25.32% net income margin and 16.47% ROE, though recent Q1 2026 earnings missed expectations. Analyst consensus is mixed with 28% buy ratings and a $113.57 price target below current levels. Recent developments include strong dividend performance and upcoming Q2 2026 results announcement on August 6, 2026.
The outlook remains cautiously optimistic with solid profitability and dividend stability, but faces headwinds from recent earnings misses and premium valuation pressure. Key opportunities include continued growth in Japan and U.S. markets, while risks involve medical cost inflation and uneven revenue trends. The stock's current premium to analyst targets suggests limited near-term upside potential.
Avient Corporation (AVNT) trades at $38.89, up 4.23% today, reflecting positive momentum. The stock exhibits a bullish technical outlook with strong analyst support (12 Buy, 8 Hold, 0 Sell). Recent quarterly earnings have consistently beaten estimates, with Q1 2026 EPS of $0.83 surpassing the $0.81 forecast. The company maintains solid fundamentals, including a P/E of 22.58 and net income margin of 4.81%, while recent news highlights innovation in non-PFAS barrier technology and new dielectric thermoplastics.
The outlook for AVNT is positive, driven by earnings outperformance, strategic product launches, and favorable analyst sentiment. Key opportunities include growth in 5G/6G materials and sustainable packaging solutions. Risks involve exposure to economic cycles impacting demand and competitive pressures in the specialty materials sector. Investors should weigh strong fundamentals against market volatility and execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AFLAC Incorporated
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →About Avient Corporation
Avient Corporation is a global leader in specialized and sustainable material solutions. Formed from the legacy of PolyOne and Clariant’s masterbatch business, it provides highly engineered polymer formulations, color systems, and advanced composites that enhance the performance and sustainability of products in industries like healthcare, defense, and consumer packaging.
Read more on AVNT →
